Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

110.44USD
2 Jul 2015
Change (% chg)

-- (--)
Prev Close
$110.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
707,388
52-wk High
$138.85
52-wk Low
$33.01

AGIO.O

Chart for AGIO.O

About

Agios Pharmaceuticals, Inc. (Agios) is a biopharmaceutical company. The Company is engaged in the discovery and development of orally available small molecule medicines for the treatment of cancer and rare genetic disorders (RGDs) of metabolism using cellular metabolism as a platform. It is also engaged in the identification and... (more)

Overall

Beta: --
Market Cap(Mil.): $4,119.21
Shares Outstanding(Mil.): 37.30
Dividend: --
Yield (%): --

Financials

  AGIO.O Industry Sector
P/E (TTM): -- 454.60 39.81
EPS (TTM): -1.34 -- --
ROI: -15.78 -4.37 16.23
ROE: -16.86 -5.27 17.36
Search Stocks

Agios leukemia drug demonstrates impressive response rate: study

- Forty percent of patients, most with a particularly aggressive form of leukemia, responded to an experimental Agios Pharmaceuticals Inc drug, including several who experienced complete remission, according to data presented on Friday.

12 Jun 2015

UPDATE 1-Agios leukemia drug demonstrates impressive response rate-study

June 12 - Forty percent of patients, most with a particularly aggressive form of leukemia, responded to an experimental Agios Pharmaceuticals Inc drug, including several who experienced complete remission, according to data presented on Friday.

12 Jun 2015

Agios leukemia drug demonstrates impressive response rate-study

June 12 - Forty percent of patients, most with a particularly aggressive form of leukemia, responded to an experimental Agios Pharmaceuticals Inc drug, including several who experienced complete remission, according to data presented at a medical meeting on Friday.

12 Jun 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks